ATLANTA, GA – March 29, 2016 – LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSX-V: LMD) announced that its subsidiary, LED Dental Inc., has now received 510K approval from the FDA for its new TuxedoTM digital intraoral radiography system to be marketed and sold in the United States.
The TuxedoTM imaging platform, consisting of an advanced intraoral sensor and LED’s image management software, is the latest addition to the Company’s dental imaging portfolio. The system, designed as a digital replacement for analog dental film, produces high-quality intraoral radiographic images that integrate well with most dental practice management systems due to its open system architecture. With true resolution of >20 line pairs/mm, the TuxedoTM sensor provides unparalleled image quality that is among the best in the industry.
“We’re excited about bringing our own digital intraoral sensor system to market,” stated David Gane, CEO, LED Medical Diagnostics. “This launch is consistent with our objectives to expand and diversify our imaging product portfolio with high margin imaging products and services.”
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX-V under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 884.952.7327 or visit www.leddental.com/investor-relations.